Cathelicidin LL-37: A Multitask Antimicrobial Peptide

被引:0
|
作者
Robert Bucki
Katarzyna Leszczyńska
Andrzej Namiot
Wojciech Sokołowski
机构
[1] University of Pennsylvania,Institute for Medicine and Engineering
[2] Medical University of Bialystok,Department of Diagnostic Microbiology
[3] Medical University of Bialystok,Department of Anatomy
来源
Archivum Immunologiae et Therapiae Experimentalis | 2010年 / 58卷
关键词
Antibacterial agents; Bacteria; Infection; hCAP-18;
D O I
暂无
中图分类号
学科分类号
摘要
The antimicrobial peptide LL-37 is the only known member of the cathelicidin family of peptides expressed in humans. LL-37 is a multifunctional host defense molecule essential for normal immune responses to infection and tissue injury. LL-37 peptide is a potent killer of different microorganisms with the ability to prevent immunostimulatory effects of bacterial wall molecules such as lipopolysaccharide and can therefore protect against lethal endotoxemia. Additional reported activities of LL-37 include chemoattractant function, inhibition of neutrophil apoptosis, and stimulation of angiogenesis, tissue regeneration, and cytokine release (e.g. IL-8). Cellular production of LL-37 is affected by multiple factors, including bacterial products, host cytokines, availability of oxygen, and sun exposure through the activation of CAP-18 gene expression by vitamin D3. At infection sites, the function of LL-37 can be inhibited by charge-driven interactions with DNA and F-actin released from dead neutrophils and other cells lysed as the result of inflammation. A better understanding of LL-37’s biological properties is necessary for its possible therapeutic application for immunomodulatory purposes as well as in treating bacterial infection.
引用
收藏
页码:15 / 25
页数:10
相关论文
共 50 条
  • [21] The Human Cathelicidin Antimicrobial Peptide LL-37 Promotes the Growth of the Pulmonary Pathogen Aspergillus fumigatus
    Sheehan, Gerard
    Bergsson, Gudmundur
    McElvaney, Noel G.
    Reeves, Emer P.
    Kavanagh, Kevin
    INFECTION AND IMMUNITY, 2018, 86 (07)
  • [22] Antimicrobial peptide LL-37 in human atherosclerosis
    Edfeldt, K.
    Agerberth, B.
    Rottenberg, M. E.
    Gudmundsson, G. H.
    Mandal, K.
    Xu, Q. B.
    Hansson, G. K.
    Yan, Z. Q.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 407 - 407
  • [23] Expression of a human cathelicidin antimicrobial peptide, LL-37, in amniotic fluid with neonatal or maternal infection
    Yoshio, H
    Yamada, M
    Yoshida, M
    Takeuchi, A
    Fujii, S
    Kunii, Y
    Kageyama, M
    Yokoi, Y
    Yamauchi, Y
    Agerberth, B
    PEDIATRIC RESEARCH, 2005, 58 (02) : 427 - 427
  • [24] NMR structure of the cathelicidin-derived human antimicrobial peptide LL-37 in dodecylphosphocholine micelles
    Porcelli, Fernando
    Verardi, Raffaello
    Shi, Lei
    Henzler-Wildman, Katherine A.
    Ramamoorthy, Ayyalusamy
    Veglia, Gianluigi
    BIOCHEMISTRY, 2008, 47 (20) : 5565 - 5572
  • [25] Regulated expression of a unique antimicrobial peptide, cathelicidin LL-37, by human colon epithelium.
    Hase, K
    Eckmann, L
    Leopard, JD
    Varki, N
    Kagnoff, MF
    GASTROENTEROLOGY, 2001, 120 (05) : A182 - A182
  • [26] Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents
    Tzitzilis, Athanasios
    Boura-Theodorou, Anastasia
    Michail, Vassilios
    Papadopoulos, Stylianos
    Krikorian, Dimitrios
    Lekka, Marilena E.
    Koukkou, Anna-Irini
    Sakarellos-Daitsiotis, Maria
    Panou-Pomonis, Eugenia
    JOURNAL OF PEPTIDE SCIENCE, 2020, 26 (07)
  • [27] Interaction of Antimicrobial Peptide Ll-37 with Lipopolysaccharides
    Martynowycz, Michael
    Rice, Amy
    Andreev, Konstantin
    Pavinatto, Thatyane M. Nobre
    Wereszczynski, Jeff
    Gidalevitz, David
    BIOPHYSICAL JOURNAL, 2019, 116 (03) : 45A - 45A
  • [28] LL-37, the only human member of the cathelicidin family of antimicrobial peptides
    Durr, Ulrich H. N.
    Sudheendra, U. S.
    Ramamoorthy, Ayyalusamy
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2006, 1758 (09): : 1408 - 1425
  • [29] Design of Antimicrobial Peptides: Progress Made with Human Cathelicidin LL-37
    Wang, Guangshun
    Narayana, Jayaram Lakshmaiah
    Mishra, Biswajit
    Zhang, Yingxia
    Wang, Fangyu
    Wang, Chunfeng
    Zarena, D.
    Lushnikova, Tamara
    Wang, Xiuqing
    ANTIMICROBIAL PEPTIDES: BASICS FOR CLINICAL APPLICATION, 2019, 1117 : 215 - 240
  • [30] The Human Cathelicidin LL-37, a Defensive Peptide Against Rotavirus Infection
    Zohreh Hosseini
    Mohammad Bagher Habibi Najafi
    Masoud Yavarmanesh
    Angila Ataei-Pirkooh
    International Journal of Peptide Research and Therapeutics, 2020, 26 : 911 - 919